Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: patients’ selection and perspective

por Trudel, Sabrina, Moreau, Philippe, Touzeau, Cyrille
Publicado 2019

Restoring Apoptosis with BH3 Mimetics in Mature B-Cell Malignancies

por Jullien, Maxime, Gomez-Bougie, Patricia, Chiron, David, Touzeau, Cyrille
Publicado 2020

Cytokine release syndrome and tumor lysis syndrome in a multiple myeloma patient treated with palliative radiotherapy: A case report and review of the literature

por Cailleteau, Axel, Touzeau, Cyrille, Jamet, Bastien, Guimas, Valentine, Jouglar, Emmanuel, Supiot, Stéphane
Publicado 2021

Interest of FDG-PET in the Management of Mantle Cell Lymphoma

por Bailly, Clément, Carlier, Thomas, Touzeau, Cyrille, Arlicot, Nicolas, Kraeber-Bodéré, Françoise, Le Gouill, Steven, Bodet-Milin, Caroline
Publicado 2019

Current Advances in Multiple Myeloma: A Post International Myeloma Society (IMS 2022) Round Table Debate by the International Academy for Clinical Hematology (IACH)

por Bahlis, Nizar J., Costa, Luciano J., Facon, Thierry, Harousseau, Jean-Luc, Manier, Salomon, Perrot, Aurore, Touzeau, Cyrille, Mohty, Mohamad
Publicado 2023

Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS)

por Touzeau, Cyrille, Quignot, Nadia, Meng, Jie, Jiang, Heng, Khachatryan, Artak, Singh, Moushmi, Taieb, Vanessa, Chauny, Jean-Vannak, Désaméricq, Gaëlle
Publicado 2021

BCLXL PROTAC degrader DT2216 targets secondary plasma cell leukemia addicted to BCLXL for survival

por Champion, Ophélie, Soler, Alana, Maïga, Sophie, Bellanger, Céline, Pellat-Deceunynck, Catherine, Talbot, Alexis, Touzeau, Cyrille, Amiot, Martine, Gomez-Bougie, Patricia
Publicado 2023

Biological rational for sequential targeting of Bruton tyrosine kinase and Bcl-2 to overcome CD40-induced ABT-199 resistance in mantle cell lymphoma

por Chiron, David, Dousset, Christelle, Brosseau, Carole, Touzeau, Cyrille, Maïga, Sophie, Moreau, Philippe, Pellat-Deceunynck, Catherine, Le Gouill, Steven, Amiot, Martine
Publicado 2015

The REFRACT-LYMA cohort study: a French observational prospective cohort study of patients with mantle cell lymphoma

por Hanf, Matthieu, Chiron, David, de Visme, Sophie, Touzeau, Cyrille, Maisonneuve, Hervé, Jardel, Henry, Pellat-Deceunynck, Catherine, Amiot, Martine, le Gouill, Steven
Publicado 2016

Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma

por Jamet, Bastien, Bailly, Clément, Carlier, Thomas, Touzeau, Cyrille, Michaud, Anne-Victoire, Bourgeois, Mickael, Moreau, Philippe, Bodet-Milin, Caroline, Kraeber-Bodere, Françoise
Publicado 2020

Extensive myelitis with eosinophilic meningitis after Chimeric antigen receptor T cells therapy

por Le Calvez, Baptiste, Eveillard, Marion, Decamps, Paul, Aguilar, Jesus, Seguin, Amélie, Canet, Emmanuel, Grain, Audrey, Touzeau, Cyrille, Tessoulin, Benoît, Gastinne, Thomas
Publicado 2022

P907: EFFICACY AND SAFETY OF ELRANATAMAB IN HIGH-RISK PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3

por Touzeau, Cyrille, Bahlis, Nizar J, Maisel, Christopher, Karlin, Lionel, Nina Varshavsky-Yanovsky, Asya, Leip, Eric, Conte, Umberto, Viqueira, Andrea, Larson, Sarah M.
Publicado 2023

FDG-PET/CT, a Promising Exam for Detecting High-Risk Myeloma Patients?

por Michaud-Robert, Anne-Victoire, Jamet, Bastien, Bailly, Clément, Carlier, Thomas, Moreau, Philippe, Touzeau, Cyrille, Bourgeois, Mickael, Kraeber-Bodere, Françoise, Bodet-Milin, Caroline
Publicado 2020

BH3-profiling identifies heterogeneous dependency on Bcl-2 family members in Multiple Myeloma and predicts sensitivity to BH3 mimetics

por Touzeau, Cyrille, Ryan, Jeremy, Guerriero, Jennifer L., Moreau, Philippe, Chonghaile, Triona Ni, Gouill, Steven Le, Richardson, Paul, Anderson, Kenneth, Amiot, Martine, Letai, Anthony
Publicado 2015

Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma

por Jamet, Bastien, Zamagni, Elena, Nanni, Cristina, Bailly, Clément, Carlier, Thomas, Touzeau, Cyrille, Michaud, Anne-Victoire, Moreau, Philippe, Bodet-Milin, Caroline, Kraeber-Bodere, Françoise
Publicado 2020

PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients

por Bailly, Clément, Leforestier, Rodolphe, Jamet, Bastien, Carlier, Thomas, Bourgeois, Mickael, Guérard, François, Touzeau, Cyrille, Moreau, Philippe, Chérel, Michel, Kraeber-Bodéré, Françoise, Bodet-Milin, Caroline
Publicado 2017

Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes

por Seiller, Carolane, Maiga, Sophie, Touzeau, Cyrille, Bellanger, Céline, Kervoëlen, Charlotte, Descamps, Géraldine, Maillet, Laurent, Moreau, Philippe, Pellat-Deceunynck, Catherine, Gomez-Bougie, Patricia, Amiot, Martine
Publicado 2020

Glucose Metabolism Quantified by SUVmax on Baseline FDG-PET/CT Predicts Survival in Newly Diagnosed Multiple Myeloma Patients: Combined Harmonized Analysis of Two Prospective Phase...

por Michaud-Robert, Anne-Victoire, Zamagni, Elena, Carlier, Thomas, Bailly, Clément, Jamet, Bastien, Touzeau, Cyrille, Moreau, Philippe, Kraeber-Bodere, Françoise, Nanni, Cristina, Bodet-Milin, Caroline
Publicado 2020

S186: ACQUIRED RESISTANCE TO BISPECIFIC ANTIBODIES BY GENETIC OR EPIGENETIC INACTIVATION OF THE TARGET IN MULTIPLE MYELOMA

por Derrien, Jennifer, Gastineau, Sarah, Frigout, Antoine, Giordano, Nils, Cherkaoui, Mia, Gaborit, Victor, Douillard, Elise, Devic, Magali, Magrangeas, Florence, Moreau, Philippe, Minvielle, Stéphane, Touzeau, Cyrille, Letouzé, Eric
Publicado 2023

Interest of Pet Imaging in Multiple Myeloma

por Jamet, Bastien, Bailly, Clément, Carlier, Thomas, Touzeau, Cyrille, Nanni, Cristina, Zamagni, Elena, Barré, Louisa, Michaud, Anne-Victoire, Chérel, Michel, Moreau, Philippe, Bodet-Milin, Caroline, Kraeber-Bodéré, Françoise
Publicado 2019